Tumor Immunity

Immunotherapy has become an important treatment modality for cancer. However, like other therapeutic approaches, the success of immunotherapy may be limited by tumor immunity. This may occur through various mechanisms including alterations in the tumor microenvironment and poor immunogenicity. Identifying the genes and cellular processes that interfere with the success of cancer immunotherapy will be necessary to design new treatment strategies. The Human Tumor Immunity Primer Library contains primer sets that may be used for PCR arrays to measure gene expression associated with a comprehensive set of tumor immunity genes.